In vitro and in vivo antibacterial activity of cefoperazone.
D000818:Animals; D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy; D002352:Carrier Proteins / Q000378:metabolism; D002437:Cefazolin / Q000494:pharmacology; D002438:Cefoperazone; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004355:Drug Stability; D051379:Mice; D008826:Microbial Sensitivity Tests; D010406:Penicillins; D001618:beta-Lactamases / Q000378:metabolism
D002352:Carrier Proteins; D002511:Cephalosporins; D010406:Penicillins; D002438:Cefoperazone; D001618:beta-Lactamases; D002437:Cefazolin